Mustang Bio (MBIO) Interest Expenses (2016 - 2025)
Mustang Bio (MBIO) posted quarterly Interest Expenses of $86000.0 for Q1 2025, down 68.03% year-over-year from $269000.0 in Q1 2024, and down 32.81% quarter-over-quarter from $128000.0 in Q4 2024.
Mustang Bio (MBIO) Interest Expenses (2016 - 2025) Analysis & Trends
Mustang Bio (MBIO) has reported Interest Expenses for 10 consecutive years, with $86000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Interest Expenses fell 68.03% year-over-year to $86000.0; the TTM figure through Dec 2025 stood at $86000.0 (down 33.85% YoY), while the FY2025 annual figure was $86000.0, down 99.94% from the prior year.
- Interest Expenses eased to $86000.0 in Q1 2025 per MBIO's latest filing, from $128000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $3.3 million in Q4 2022 and bottomed at -$3000.0 in Q4 2023.
- Historically, Interest Expenses has averaged $788941.2 across 5 years, with a median of $230000.0 in 2022.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 83575.0% — and 2023, when it slumped 100.09%.
- Mustang Bio's Interest Expenses stood at $4000.0 in 2021, then soared by 83575.0% to $3.3 million in 2022, then sank by 100.09% to -$3000.0 in 2023, then surged by 4366.67% to $128000.0 in 2024, then tumbled by 32.81% to $86000.0 in 2025.
- Business Quant data shows MBIO's Interest Expenses at $86000.0 in Q1 2025, $128000.0 in Q4 2024, and $1000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 269,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 2.93 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Dec 31, 2022 | 3.35 Mn |